1. Home
  2. LXEO vs TSSI Comparison

LXEO vs TSSI Comparison

Compare LXEO & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$5.16

Market Cap

369.8M

Sector

N/A

ML Signal

HOLD

Logo TSS Inc.

TSSI

TSS Inc.

HOLD

Current Price

$16.44

Market Cap

315.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXEO
TSSI
Founded
2017
2004
Country
United States
United States
Employees
N/A
161
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
369.8M
315.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LXEO
TSSI
Price
$5.16
$16.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$18.44
$16.00
AVG Volume (30 Days)
667.0K
1.4M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
39.81
N/A
EPS
N/A
N/A
Revenue
$654,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.67
P/E Ratio
N/A
$42.71
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$6.87
52 Week High
$10.99
$31.94

Technical Indicators

Market Signals
Indicator
LXEO
TSSI
Relative Strength Index (RSI) 43.41 66.45
Support Level $4.95 $13.98
Resistance Level $6.26 $21.38
Average True Range (ATR) 0.38 0.97
MACD 0.00 0.36
Stochastic Oscillator 36.34 88.57

Price Performance

Historical Comparison
LXEO
TSSI

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

About TSSI TSS Inc.

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.

Share on Social Networks: